MedPath

Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)

Conditions
Silicosis
Registration Number
NCT01338064
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

Silicosis is well-known occupational disease caused by free crystalline silica (silicon dioxide) and is marked by inflammation and pulmonary fibrosis. There are cumulative evidences that exposure to Caesar stone (quartz surface products that manufactured from up to 93% quartz, polymer resins and pigments) is particularly dangerous to exposed workers.

Goals: To examine marble workers exposed to Caesar Stone in order to propose a working plan of surveillance and prevention by biological monitoring.

Detailed Description

Study participants would be recruited during two years of the study. They will be asked to come to a single visit at Pulmonary Laboratory of Tel Aviv Medical Center. During the meeting, participants will be given a precise explanation about the tests they will perform and after signing the informed consent will perform following tests:

1. Induced sputum (IS) - will be done after pretreatment with short acting beta-2 agonist and 3% saline will be administrated by an ultrasonic nebulizer for up to 20 min. Differential cell count, particle size distribution test of the particulate matter (with a Eyetech Analyzer (Ankersmid, Yokneam, Israel)will be done from IS samples and evaluation the activity of Heme oxygenase 1 (HO-1) protein from IS supernatants.

2. EBC-Exhaled Breath Condensate-will be done by condensation expiratory air and particulate matter and markers of oxidation will be measured.

3. Participants will be asked to complete occupational questionnaire.

4. Pulmonary function tests (PFTs): The measurement will be performed using standard protocols according to American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines. Including Lung diffusion testing.

Laboratory tests of induced sputum and EBC will be done within a week of a participant visit. Analysis of data will be done after the completion of data collection and laboratory tests.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
150
Inclusion Criteria
  1. male
  2. 18-70 years old
  3. At least six months of professional exposure to Caesar stone
Exclusion Criteria
  1. Other occupational exposure (welding of any kind)
  2. Chronic Obstructive Pulmonary Disease (COPD), tuberculosis, asthma, autoimmune disease in healthy exposed workers
  3. Interstitial lung disease in exposed workers with clinically approved silicosis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evidence of clinically definite silicosis according to ATS/ERS guidelinesone day

1. Occupational physician examination

2. Pulmonary function tests (PFTs): The measurement will be performed using standard protocols according to ARS/ERS guidelines. Including Lung diffusion testing

3. Computed Tomography (CT) test if need

Secondary Outcome Measures
NameTimeMethod
Differential cell countone day

Differential cell count will be done from Induced sputum (IS) samples.

Particle size distribution of the particulate matterone day

Particle size distribution test of the particulate matter (with a Eyetech Analyzer (Ankersmid, Yokneam, Israel) will be done from Induced sputum (IS) samples and EBC-Exhaled Breath Condensate.

The activity of Heme oxygenase 1 (HO-1) proteinone day

Evaluation the activity of Heme oxygenase 1 (HO-1) protein will be done from Induced sputum (IS) supernatants.

Markers of oxidationone day

Markers of oxidation will be measured will be measured in EBC-Exhaled Breath Condensate.

Trial Locations

Locations (1)

Pulmonary Laboratory of Tel Aviv Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

© Copyright 2025. All Rights Reserved by MedPath